Latest Breaking News On - Research at christ hospital - Page 1 : comparemela.com

A coronary sinus reducer met one of two primary endpoints by reducing refractory angina in the ORBITA-COSMIC trial, but not the second, improvement in perfusion.

City ofUnited kingdomUnited statesNorth carolinaDuke universityMichaelj foleyJennifera rymerTimothyd henryRashak al lameeAmerican college of cardiologyResearch at christ hospitalImperial college healthcareLindner centerCanadian cardiovascular societyImperial college londonDuke university school of medicine